Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RA-PROPR Pragmatic Trial in Rheumatoid Arthritis
NCT04692493Phase 3Recruiting
- Sponsor
- University of Alabama at Birmingham
- Start
- Sep 2021
- Primary completion
- May 2029
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial in rheumatoid arthritis (RA) (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Health Assessment Questionnaire at 12 months. Started Sep 2021; status: recruiting.
02
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT04692493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04692493.